Baboons (Papio hamadryas ssp.) have been used to great advantage in studies of biological and environmental factors known to influence variation in risk for CVD in humans for over 60 years. 5 The baboon has been one of the more thoroughly genetically characterized non-human primate species during the past 3 decades and, as such, the goals of a majority of CVD-related studies utilizing baboons have been the detection, characterization, and identification of genes. [6] [7] [8] However, in the "post-genomics" era, their value may be more fully realized in experimental studies focused on mechanisms of development and progression of atherosclerosis with clear and direct translational implications for its diagnosis, prevention, and treatment. The baboon satisfies the majority of key criteria of an ideal animal model for many studies of CVD and related disorders. The species mimics the human subject developmentally, metabolically, and pathophysiologically; [9] [10] [11] it is large enough to allow repeated whole organism physiological and metabolic studies; it naturally develops atherosclerosis and exhibits similar responses to an atherogenic diet, including dyslipidemia and susceptibility to atherosclerosis. Also like humans, baboons exhibit individual variation in the extent of atherosclerotic lesions and have been shown to develop end-stage disease(s) comparable to those in humans. 9, 12, 13 Moreover, as in humans, quantitative variation in traditional CVD risk factors is heritable in baboons. 5 Several studies have confirmed and identified novel genes that play roles in the mediation of response to atherogenic diets (e.g. 6, 8, [14] [15] [16] ). Further, baboon growth, development, maturation, and aging follow a generalized Old World primate pattern [17] [18] [19] [20] shared with humans, and their longer lifespans compared to small animal models provide unique opportunities to better observe the development and progression of atherosclerosis, its comorbidities, and consequent disease endpoints. These characteristics correspond to those of the "ideal animal model" for CVD-related studies-that is, one likely to have potential for more immediate translation to humans. 13 Many researchers eschew the baboon and related non-human primates in favor of smaller, shorter-lived, less phenotypically and genetically variable animals like inbred mice, despite well-recognized dissimilarities of the latter to the human condition. 21 The most frequently raised reasons for this are the greater time and expense associated with breeding and developing atherosclerosis in a non-human primate like the baboon. 12, 13 These concerns likely are amplified by a common misperception that genetic variability in non-inbred baboon breeding colonies makes model development unpredictable, necessitating larger initial sample sizes, which further increase total costs before data collection can even begin. 21 In this study, we demonstrate that the baboon is a reliable animal model for studies related to onset, severity, and progression of atherosclerosis. We show that simple dietary manipulation (i.e., addition of cholesterol and saturated fat) for two years induces the classic features of early-stage atherosclerosis-fatty streaks and fibrous plaques 22 -as well as increased stiffness in the large and medium arteries (decreased vascular compliance), a hallmark of arteriosclerosis. Thus, a salient link between atherosclerosis and consequent CVD can be produced predictably in a time frame that accommodates a majority of current study designs. The data presented are derived from a recently completed phase of a long-term study of the interaction between diet and genes underlying variation in atherosclerosis risk factors in baboons from a single, large, six-generation pedigree, the members of which have been extensively characterized-genetically and phenotypically. 5 
| MATERIALSANDMETHODS

| Humanecareguidelines
All research procedures involving animals for this study were con- Research Institute, the host institution for the SNPRC.
| Subjectsanddiets
The subjects of the study were 173 baboons [olive baboons (Papio hamadryas anubis), yellow baboons (P. h. cynocephalus), and their hy-
brid descendants], all of which were members of a large pedigreed breeding colony developed and maintained at the SNPRC.
The study utilizes data from two groups of baboons distinguished by diet protocols. Baboons in the control diet group were fed a basal diet, low in cholesterol and fat (LCLF), for at least 7 years prior to, and for the duration of, this study. Baboons in the experimental diet group were fed the LCLF diet prior to beginning a two-year dietary challenge with a diet high in cholesterol and saturated fat (HCHF).
Data for animals in this group were obtained just prior to beginning the two-year HCHF diet challenge (while on LCLF diet), at seven weeks into the challenge, and at the end of the two-year challenge. 
| Experimentaldietgroup
The experimental diet group included 112 baboons: 47 females and 65 males. Ages ranged from 8.1 to 17.0 years. Mean age for the females was 12.6 years (range=8.7 to 17.0 years) and that of the males was 11.4 years (range=8.1 to 14.1 years).
| Arteriallesions
We assessed lesion formation in three major arteries: the aortic arch, thoracic section of the descending aorta, and the common iliac artery.
Atherosclerosis in these three arteries has been shown to be relevant to systemic risk of the disease and its complications in humans. Aortic arch atherosclerosis is an independent risk factor for ischemic stroke and recurrent vascular events; [24] [25] [26] atherosclerosis in the thoracic aorta is strongly predictive of generalized atherosclerosis 24 and coronary artery disease; 27, 28 and the common iliac arteries are the second most frequently affected blood vessels (after the arteries of the thigh) in atherosclerotic peripheral artery disease. 29 These associations have been replicated in earlier studies of baboons from this same pedigreed breeding colony. 30, 31 For the lesion studies, baboons in the control and experimental diet groups were humanely euthanized and subjected to a standard necropsy procedure. Baboons in the experimental group were euthanized after two years on HCHF diet. The three above-noted arteries were defatted and dissected longitudinally. Adventitial surfaces were adhered to chipboard, and the arteries were fixed in buffered 10% formalin and stained for 18 hour with Sudan IV in 38% isopropanol (v/v) made up as a stock solution and diluted to a consistent optical density (i.e., A 520nm =0.22±0.01).
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A team of research support staff, trained by an experienced cardiovascular pathologist, first identified fatty streaks and raised fibrous lesions (plaques) by visual inspection of the stained arterial sections. The same team assessed all arteries from which data for this study were obtained. Members of this team, trained by an experienced histomorphometrist, quantified the extent of atherosclerotic lesions (i.e., percent area covered by fatty streaks, plaques, or both when each was present) on arterial surfaces using BioQuant Image Analysis software (Nashville, TN, USA) as previously described. 33 Briefly, an entire artery was photographed and images were imported into the BioQuant software. Subsequently, regions in the imager corresponding to lesion were scanned to obtain the fraction of pixels in affected regions compared to the entire artery template. The fraction of involved pixels represented the percent of intimal surface area or the extent of a specific type of lesion in a given artery as explained. 33 Age-and sex-adjusted residuals of these measures were normalized (inverse Gaussian transformation).
| Arterialcompliance
We used a computerized central blood pressure and pulse wave analysis/pulse wave velocity (PWA/PWV) assessment system (AtCor 39 We accepted data for analyses only if the operators observed consistent, acceptable waveform profiles for at least ten seconds. Acceptable waveforms were those with in-device quality indexes (a function of mean pulse height, variation in pulse height and diastolic pressure, and the maximum rise of the peripheral waveform) greater than 80%. All assessments were performed by research staff after training by both the device manufacturer and a veterinary researcher with experience using the device with non-human primates.
| CVD-relatedbiomarkers
We also obtained data on circulating CVD risk factors, including lipids and lipoproteins, lipoprotein-related enzymes, and biomarkers of inflammation and oxidative stress from fasting blood samples collected at three time points from all animals undergoing the two-year dietary challenge and at one time point from animals in the basal LCLF diet control group for lesion studies.
| Lipidsandlipoproteins
We quantified the concentrations of the following serum lipids and lipoproteins. Total serum cholesterol (TSC) and triglyceride (TG)
concentrations were determined enzymatically using commercial reagents in a clinical chemistry analyzer. High-density lipoprotein cholesterol (HDLC) was measured in the supernatant after heparinMn+2 precipitation, and non-HDLC (V+LDLC) was calculated as the difference between total and HDLC. Concentrations of apolipoproteins AI (APOAI), B (APOB), and E (APOE) were determined using an immunoturbidometric approach with commercial reagents in a clinical chemistry analyzer. We provide detailed descriptions of the methods used in these assays elsewhere. 6, 40, 41 We used composite gradient gels to further resolve LDLs and HDLs on the basis of size 37 
| Lipoprotein-relatedenzymes
We measured serum activity levels of two lipoprotein-associated enzymes, lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) and paraoxonase 1 (PON1) on two substrates. We determined the activity of the APOB-associated enzyme, Lp-PLA 2 (μmol/min/L), using 2-thio-PAF as substrate in a commercial microplate-based colorimetric assay. 42 We used a microplate-based colorimetric assay 14 to measure the activity (μmol/min/L) of HDL-associated enzyme, PON1, with paraoxon as substrate (PON1-para) in one case and arylesterase with phenylacetate as substrate (PON1-aryl) in the other.
| Inflammationandoxidativestress
We assayed interleukin-8 (IL-8; pg/mL) using a sandwich-style enzymelinked immunoassay kit, as suggested by the manufacturer (R&D Systems, Inc., Minneapolis, MN, USA). 42 Total antioxidant status (TAS), reflecting the overall antioxidant capacity of serum, was defined as the ability to
by metmyoglobin with the use of a kit from Calbiochem (San Diego, CA, USA). 41 We used a high-sensitivity assay kit (Kamiya Biomedical, Seattle, WA, USA), with a latex particle-enhanced immunoturbidometric method, to measure C-reactive protein (CRP) concentrations (mg/L). We quantified the Von Willebrand factor (vWF; expressed as percentage of an international standard value 41 ) using a sandwich-style enzyme-linked immunoassay kit (Diagnostica Stago, Parsippany, NJ, USA).
| Dataanalysis
Summaries of raw data are presented as means, standard deviations, and medians. Unless otherwise indicated, data in all analyses were inormalized residuals of the quantitative variables after adjustments for the significant mean effects of common covariates such as sex, age, body weight. Because the data are derived from related animals (mean kinship coefficient=0.03, between second and first cousins), we used a maximum-likelihood-based variance decomposition approach, implemented in SOLAR, 43 that is designed to account for kinship in data from pedigrees to estimate both the mean effects of covariates and appropriately weighted correlations. We used likelihood ratio tests to assess significance of these parameter estimates.
We used a Bayesian model selection approach, also implemented in SOLAR, to identify the subset of the highly intercorrelated CVD risk factors contributing the most independent information to lesion ex- 
| RESULTS
| Arteriallesions
We observe atherosclerotic lesions (fatty streaks and/or plaques) in the aortic arch, thoracic aorta, and common iliac artery ( Figure 1 ).
Lesions are observed in at least one artery from 111 of 112 animals (99%) that completed the two-year diet challenge, more than twice the 40% prevalence observed in the same three arteries harvested from 20 dietary control animals. All three arteries are affected in 109 baboons ( Table 2 ). The mean percentages of the areas covered by lesions (fatty streaks plus plaques, when the latter are present) in all three arteries from the challenge diet group are approximately 2.6 times to 5.0 times larger than in those from controls (P<.0004).
Two-sample t tests show no difference between the percentages of areas covered by lesions in the aortic arch and common iliac artery (*P=.694), but the means for each of these arteries differ significantly from that of the thoracic aorta (*P=.0002).
Extent of atherosclerotic lesions for the aortic arch and thoracic aorta, but not the common iliac artery, differs by sex. Mean percentages for areas affected in females are significantly greater than those in males in both the aortic arch (P=.00052) and the thoracic aorta (P=.000009), but not in the common iliac artery (P=.768). These analyses also reveal a significant effect of age on lesion extent in the aortic arch (P=.0023) and common iliac artery (P=.039), but not in the thoracic aorta (P=.42), even when accounting for the possible confounding effect of variation in days on the challenge diet which does exert a significant mean effect on percent area covered by fatty streaks in the thoracic aorta (P=.032).
The percentages of the areas in the three arteries covered by ath- HCHF, high-cholesterol, high-fat atherogenic challenge diet; LCLF, low-cholesterol, low-fat baseline diet; n, number of individuals with affected artery; x̅ (SD), mean and (standard deviation); min, minimum observed value; max, maximum observed value.
| CirculatingbiomarkersofCVDrisk
a P values derived from comparison between extent of fatty streaks in two-year diet-challenged group and control group by means of two-sample t tests.
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F I G U R E 2 (A-J) Serum biomarkers of lipid/lipoprotein metabolism, inflammation, and oxidative stress measured at three time points in 112 baboons in the two-year HCHF diet challenge study: at baseline (Week 0, LCLF diet), seven weeks into the HCHF diet challenge ( 
| Arterialcompliance(stiffness)
Data on arterial compliance and blood pressures come from 50 animals sampled randomly from the 109 in which lesions of some size are seen in all three arteries after being fed the HCHF diet for 2 years and from 41 adult baboons fed the LCHF diet for 2 years ( All blood pressures: mm Hg; heart rate: beats per minute; augmentation pressure: difference between peak aortic pressure at second and first systolic peak; augmentation index: augmentation pressure/ pulse pressure × 100; pulse wave velocity: m/s). Mean, arithmetic mean; sd, standard deviation; med, median; Δ, direction of mean differences between two groups of baboons (i.e., controls fed only the LCLF diet and challenge animals fed the HCHF challenge diet for two years); *P=.05; and **P=.01; ns, no nominally significant difference-i.e., P≥.05.
T A B L E 4
Arterial compliance examined by pulse wave analysis using applanation tonometry in controls fed a basal LCLF diet and in challenge animals fed a HCHF diet for two years 
| DISCUSSION
Ultimately, successful treatment and/or prevention of atherosclerosis will require an understanding of mechanisms by which interactions between CVD risk factors and the cells of the vascular endothelium result in the development and progression of arterial lesions from simple fatty streaks to unstable plaques. Although recent advances in clinical diagnostic and research technologies (e.g., imaging modalities) have made it possible to detect and determine the extent of atherosclerosis in human research participants and patients with greater precision than ever before, many critical studies of disease onset and progression, and responses to therapy remain impractical, if not impossible, in humans. It is for this reason that we turn to animal models to elucidate pathogenetic steps and causalities in atherosclerosis. 47 Our study shows that the baboon is a suitable model for human atherosclerosis studies in that the disease can be reliably induced in a time frame which will facilitate rapid research progress from discovery to translational outcomes in our own species. Together, the range of interindividual phenotypic variation in the extent of lesions and their association with biomarkers of CVD risk and pathophysiology observed in nearly 100% of the baboons studied correspond well with what is observed in the early stages of atherosclerosis in humans. 22, 33 All lesions observed following a two-year exposure to the atherogenic diet, including those underlying raised areas, include fatty streaks.
These fatty streaks, observed and described in reports of studies conducted over the past 35 years with baboons from earlier generations of this same pedigreed breeding colony (e.g. 31 ), correspond to AHA type II lesions, 48 from which more complicated plaques arise.
As other studies of biomaterials and data from these same baboons Our observations not only reinforce the validity of baboon model for studies relevant to our own species, but they also point to the utility of baboons for studies involving experimental manipulation and/ or control, which may be impractical in humans, designed to assess genetic influences on development, severity, and progression of atherosclerosis, as well as responsiveness of the disease to therapeutic interventions.
As reported for this species in the past, 9,31 prolonged exposure to the HCHF diet significantly increased both prevalence and extent of atherosclerotic lesions. However, our observation of lesions in 40% The degree of correspondence between observations on arterial stiffness (arteriosclerosis) in this study and those in humans strongly supports the value of the pedigreed baboon as a model for research on the effects of long-term exposures to diet and other disease risk factors on atherosclerosis and its vascular consequences, which underlie variation in risk, severity, and progression of CVD.
While the pedigreed baboon model for early-stage atherosclerosis certainly could be exploited for an analog of a human CVD epidemiological study (e.g., to mimic the effects of an average diet on the cardiovascular health of a human population), that is not our objective here. For our purposes, the principal value of the model derives from our ability to use diet as a tool to reliably and quickly induce atherosclerotic lesions on which we can conduct studies of the molecular and cellular determinants of variation in their initiation, development, severity, and progression, all in a species exhibiting greater genetic, anatomic, and physiological proximity to our own than most other animal models.
It is true that the relative amounts of cholesterol and fats in the HCHF atherogenic diet exceed those consumed on a daily basis by the average person in the USA. 69 This diet has been designed to overcome the effects genes on interindividual variation in susceptibility to endothelial damage and it does: increasing the probability of atherogenesis to nearly 100% in our studies.
Elevated though they are, the amounts of fat and cholesterol in the HCHF atherogenic diet are not so extreme as to compromise the relevance of the model to the human condition. Recent estimates place the mean fat intake for US men and women at approximately 33% of daily calories, 69 just above the recommended upper limit of 30% in the Dietary Guidelines for Americans. 70 With 40% of total calories due to fat, the HCHF diet fed to the baboons certainly would be considered an unhealthy one, but not so extreme as those used in some short-term diet studies with human participants (e.g., 55% 71 Relative to that consumed on a daily basis by the average American, the amount of cholesterol in the HCHF atherogenic diet also is very high. As indicated in our description of the diet (Materials and Methods), the average amount consumed daily by each baboon was equivalent to that found in ten to twelve large eggs. However, compared to humans, many non-human primate species exhibit substantial variability in their responses to dietary cholesterol. 76 Consequently, investigators working with several species have used very high dietary cholesterol relative to standard American diets (from 0.5 to 2 mg/kcal or 1250-5000 mg/2500 kcal) to enhance the effects of dietary fats and accelerate atherogenesis.
Because we repeatedly have shown that interindividual variation in most "traditional" CVD risk factors-and now, likely lesion extenthas a heritable component, the considerable variation we observe in lesion development in both experimental and control baboons is a desirable characteristic, rather than a conundrum as some may describe it. 21 Indeed, it makes a pedigreed breeding colony of baboons, such as those from which these animals are derived, valuable for a broader range of studies than any single inbred line of most smaller mammalian species. Knowledge of pedigree relationships can be exploited to identify and select animals based on degrees of both phenotypic and relevant genetic similarity (even prior to, or without, molecular genetic characterization) for case-control type study designs, for example.
It also allows for production of offspring that are phenotypically and genetically similar for study. Further, it makes possible larger-scale, pedigree-based studies with sufficient statistical power for detecting the effects of individual genes, gene-by-environment (e.g., diet, pharmaceutical agent) interactions, and more. All these approaches have benefited CVD research projects with baboons from this pedigreed colony. 35, 54, 56, 77, 78 
| CONCLUSIONS
Based on our results, we conclude that a diet high in cholesterol and fat can be employed to reliably produce a baboon model of human atherosclerosis that has greater translational potential than other frequently used species. This potential is attributable to the fact that the development of atherosclerotic lesions and their functional consequences (e.g., decreased arterial compliance), as well as interrelationships among "classical" CVD risk factors, closely mirror those in humans. In addition, our study shows that baboons exhibit variation in extent of lesions as seen in humans. The potential for translation is further enhanced by the phylogenetic proximity of baboons to humans, which results in a high degree of genetic, anatomic, and physiological correspondence between the two species.
Given that the HCHF diet alone can induce a disease state in nearly 100% of adult baboons in two years or less, the baboon is a practical model for research into the pathobiology of atherosclerosis and its consequences for CVD and comorbidities. Considering the time frames associated with most independent investigator-initiated, 
